Catalent Inc

CTLT

Company Profile

  • Business description

    Catalent is a contract development and manufacturing organization, or CDMO. It operates under four segments: biologics, softgel and oral technologies, oral and specialty delivery, and clinical supply services. Catalent derives its revenues primarily from long-term supply agreements with pharmaceutical customers. The company provides a range of development and manufacturing solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products throughout the entire life cycle of a product from the drug development process to commercial supply. Catalent has over 50 facilities across four continents.

  • Contact

    14 Schoolhouse Road
    SomersetNJ08873
    USA

    T: +1 732 537-6200

    E: [email protected]

    https://www.catalent.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    30 June 2025

    Employees

    16,900

Catalent Inc News & Analysis

stocks

11 stocks to examine through a sustainability lens

Investors can use ESG information in many useful ways.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,634.6067.600.79%
CAC 407,213.3214.870.21%
DAX 4019,146.17141.390.74%
Dow JONES (US)43,870.35461.881.06%
FTSE 1008,149.2764.200.79%
HKSE19,601.11103.90-0.53%
NASDAQ18,972.426.280.03%
Nikkei 22538,187.05160.880.42%
NZX 50 Index12,918.97153.731.20%
S&P 5005,948.7131.600.53%
S&P/ASX 2008,391.5068.500.82%

Market Movers